Quest Diagnostics Incorporated (DGX) has an average broker rating of 3.02, which is interpreted as a Hold, as rated by 16 equity analysts. Nonetheless, 1 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 13 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold. 1 brokerage firm advices Strong Sell on the share due to lack of confidence about the future of the company. 1 considers that the stock is a Sell.
Quest Diagnostics Incorporated (DGX) : Currently there are 12 street experts covering Quest Diagnostics Incorporated (DGX) stock. The most bullish and bearish price target for the stock is $84 and $70 respectively for the short term. The average price target of all the analysts comes to $75.58. The estimated standard deviation from the target is $3.65.
Quest Diagnostics Incorporated (NYSE:DGX): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $80.91 and $80.27 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $81.40. The buying momentum continued till the end and the stock did not give up its gains. It closed at $81.19, notching a gain of 0.15% for the day. The total traded volume was 1,496,183 . The stock had closed at $81.07 on the previous day.
Also, Equity analysts at the Brokerage firm Jyske Bank downgrades its rating on Quest Diagnostics Incorporated (NYSE:DGX). The rating major has initiated the coverage with sell rating on the shares. The rating by the firm was issued on June 24, 2016. The company shares have rallied 16.33% from its 1 Year high price. On Jun 30, 2016, the shares registered one year high at $81.41 and the one year low was seen on Feb 9, 2016. The 50-Day Moving Average price is $77.94 and the 200 Day Moving Average price is recorded at $71.84.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.